A Study to Find a Suitable Dose of ASP8731 and Check for Medical Problems at Each Dose in Healthy Adults
Clinical trial NCT05167526 · TERMINATED
Trial details
- NCT number
- NCT05167526
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-07
- Primary completion
- 2022-11-10
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.